MULTICENTER REAL-WORLD EXPERIENCE OF USTEKINUMAB TROUGH LEVELS AND ANTIBODIES IN CROHN'S DISEASE MAINTENANCE THERAPY

被引：0
|
作者：
Ramos, Guilherme Piovezani
Tharayil, Vivek
Kurdi, Ahmed T.
Bali, Aman S.
Rolak, Stacey C.
Fredrick, Thomas W.
Neto, Manuel B. Braga
Vinsard, Daniela Guerrero
Urquhart, Siri A.
Dunleavy, Katie A.
Bakhshi, Zeinab
Tariq, Raseen
Becker, Michelle
Johnson, Amanda M.
Pasha, Shabana F.
Hashash, Jana G.
Harmsen, William S.
Willrich, Maria Alice V.
Loftus, Edward V.
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1522
引用
收藏
页码：S802 / S802
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of ustekinumab in Crohn's disease: A real-world study from Australia
    Ramaswamy, P. Kakkadasam
    Moattar, H.
    Sawyer, E.
    Edwards, J.
    Shukla, D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S564 - S565
  • [42] REAL-WORLD EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND VEDOLIZUMAB IN ELDERLY PATIENTS WITH CROHN'S DISEASE
    Garg, Rajat
    Aggarwal, Manik
    Mohammed, Abdul
    Achkar, Jean-Paul
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin L.
    Rieder, Florian
    Qazi, Taha
    Regueiro, Miguel D.
    Click, Benjamin H.
    GASTROENTEROLOGY, 2021, 160 (06) : S560 - S560
  • [43] Relationship Between Serum Ustekinumab Trough Concentration and Clinical and Biochemical Disease Activity: A Real-World Study in Adult Patients with Crohn’s Disease
    Khue M. Nguyen
    Vandita Y. Mattoo
    Sara Vogrin
    Chamara Basnayake
    William R. Connell
    Nik S. Ding
    Emma Flanagan
    Michael A. Kamm
    Mark Lust
    Ola Niewiadomski
    Julien D. Schulberg
    Emily K. Wright
    European Journal of Drug Metabolism and Pharmacokinetics, 2023, 48 : 271 - 279
  • [44] Relationship Between Serum Ustekinumab Trough Concentration and Clinical and Biochemical Disease Activity: A Real-World Study in Adult Patients with Crohn's Disease
    Nguyen, Khue M.
    Mattoo, Vandita Y.
    Vogrin, Sara
    Basnayake, Chamara
    Connell, William R.
    Ding, Nik S.
    Flanagan, Emma
    Kamm, Michael A.
    Lust, Mark
    Niewiadomski, Ola
    Schulberg, Julien D.
    Wright, Emily K.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (03) : 271 - 279
  • [45] REAL-WORLD EFFECTIVENESS AND SAFETY OF USTEKINUMAB FOR THE TREATMENT OF CROHN'S: THE SCOTTISH USTEKINUMAB COHORT
    Plevris, Nikolas
    Robertson, Andrew
    Fulforth, James
    Hall, Rebecca
    Jenkinson, Philip
    Campbell, Iona
    Kane, Claire
    Arnott, Ian
    Sutherland, Diarmid
    Veryan, Jennifer
    Saunders, Jennifer
    Lam, Wai
    Naismith, Graham
    Chuah, Cher
    Kelly, Christopher
    Watts, David
    Gaya, Daniel
    Macdonald, Jonathan
    Sennan, John-Paul
    Jafferbhoy, Hasnain
    Mowat, Craig
    Bain, Gillian
    Jones, Gareth
    Lees, Charlie
    GUT, 2021, 70 : A112 - A113
  • [46] Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease
    Painchart, Claire
    Brabant, Severine
    Duveau, Nicolas
    Nachury, Maria
    Desreumaux, Pierre
    Branche, Julien
    Gerard, Romain
    Prevost, Clementine Lauriot Dit
    Wils, Pauline
    Lambin, Thomas
    Boualit, Medina
    Labalette, Myriam
    Pariente, Benjamin
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (05) : 1445 - 1452
  • [47] Long-term real-world data of ustekinumab in Crohn's Disease - the Stockholm ustekinumab study - STOCUSTE
    Bello, F.
    Lordal, M.
    Johansson, F.
    Sabhan, H.
    Muhsen, S.
    Borin, A.
    Forsberg, O.
    Wennerstrom, C.
    Soderman, C.
    Almer, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I130 - I131
  • [48] Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn’s Disease
    Claire Painchart
    Séverine Brabant
    Nicolas Duveau
    Maria Nachury
    Pierre Desreumaux
    Julien Branche
    Romain Gérard
    Clémentine Lauriot Dit Prevost
    Pauline Wils
    Thomas Lambin
    Médina Boualit
    Myriam Labalette
    Benjamin Pariente
    Digestive Diseases and Sciences, 2020, 65 : 1445 - 1452
  • [49] Ustekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis
    Godoy Brewer, Gala M.
    Salem, George
    Afzal, Muhammad A.
    Limketkai, Berkeley N.
    Haq, Zadid
    Tajamal, Maryam
    Melia, Joanna
    Lazarev, Mark
    Selaru, Florin M.
    Parian, Alyssa M.
    BMJ OPEN GASTROENTEROLOGY, 2021, 8 (01):
  • [50] Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
    Sandborn, William J.
    Gasink, Christopher
    Gao, Long-Long
    Blank, Marion A.
    Johanns, Jewel
    Guzzo, Cynthia
    Sands, Bruce E.
    Hanauer, Stephen B.
    Targan, Stephan
    Rutgeerts, Paul
    Ghosh, Subrata
    de Villiers, Willem J. S.
    Panaccione, Remo
    Greenberg, Gordon
    Schreiber, Stefan
    Lichtiger, Simon
    Feagan, Brian G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (16): : 1519 - 1528
12345